Rob Carroll
Associate Professor Rob Carroll is American Society of Immunogenetics and Histocompatibility Lab Director Certified and an established Nephrologist with a translational research record in HLA and non HLA antibody assessment. His research include use of monoclonal antibodies, nanoparticles and microRNA in cancer and renal medicine. He is Principle Investigator in multiple clinical trials and also established Australia's first renal transition and young adult clinics. His research includes: 40 publications in peer-reviewed journals with 17 as first or senior author and >685 citations. He is principle investigator in the study of nivolumab in the treatment of incurable cancer post renal transplant.
Abstracts this author is presenting:
